In the tumor immune context, antigen-presenting cells (APCs) and tumor cells highly express PD-L1, and they can interact with PD-1-overexpressed T cells, leading to T-cell anergy or exhaustion (16, 17). The gene discussed is CD274; the disease is neoplasm.